[PDF][PDF] FOXK2 elicits massive transcription repression and suppresses the hypoxic response and breast cancer carcinogenesis

L Shan, X Zhou, X Liu, Y Wang, D Su, Y Hou, N Yu… - Cancer cell, 2016 - cell.com
L Shan, X Zhou, X Liu, Y Wang, D Su, Y Hou, N Yu, C Yang, B Liu, J Gao, Y Duan, J Yang…
Cancer cell, 2016cell.com
Although clinically associated with severe developmental defects, the biological function of
FOXK2 remains poorly explored. Here we report that FOXK2 interacts with transcription
corepressor complexes NCoR/SMRT, SIN3A, NuRD, and REST/CoREST to repress a cohort
of genes including HIF1β and EZH2 and to regulate several signaling pathways including
the hypoxic response. We show that FOXK2 inhibits the proliferation and invasion of breast
cancer cells and suppresses the growth and metastasis of breast cancer. Interestingly …
Summary
Although clinically associated with severe developmental defects, the biological function of FOXK2 remains poorly explored. Here we report that FOXK2 interacts with transcription corepressor complexes NCoR/SMRT, SIN3A, NuRD, and REST/CoREST to repress a cohort of genes including HIF1β and EZH2 and to regulate several signaling pathways including the hypoxic response. We show that FOXK2 inhibits the proliferation and invasion of breast cancer cells and suppresses the growth and metastasis of breast cancer. Interestingly, FOXK2 is transactivated by ERα and transrepressed via reciprocal successive feedback by HIF1β/EZH2. Significantly, the expression of FOXK2 is progressively lost during breast cancer progression, and low FOXK2 expression is strongly correlated with higher histologic grades, positive lymph nodes, and ERα/PR/HER2- status, all indicators of poor prognosis.
cell.com